Table III.
Demographic and operative information for study cohort
| % or mean | Frequency or SD | |
|---|---|---|
| Total | 154 | |
| Male sex | 71.4 | 110 |
| Race | ||
| White | 82.5 | 127 |
| Black | 9.7 | 15 |
| Other | 7.8 | 12 |
| Age, years | 67.8 | 66.3–69.3 |
| AAA size, cm | 6.3 | 6.1–6.6 |
| Creatinine baseline value, mg/dL | 1.12 | 1.06–1.18 |
| Symptomatic | 26.6 | 41 |
| HLD | 74.0 | 114 |
| HTN | 87.0 | 134 |
| Diabetes | 12.3 | 19 |
| PVD | 16.2 | 25 |
| CAD | 46.8 | 72 |
| COPD | 26.6 | 41 |
| CHF | 9.1 | 14 |
| CTD | 6.5 | 10 |
| Smoking history | 72.1 | 111 |
| CKD | 23.4 | 36 |
| ESRD | 3.9 | 6 |
| AAA class | ||
| Infrarenal | 29.2 | 45 |
| Juxtarenal | 41.6 | 64 |
| Pararenal | 13.6 | 21 |
| Suprarenal | 15.6 | 24 |
| Clamp level | ||
| Infrarenal | 29.9 | 46 |
| Suprarenal | 28.6 | 44 |
| Supramesenteric | 22.1 | 34 |
| Supraceliac | 19.5 | 30 |
| Renal flush | 33.1 | 51 |
| IMA reimplantation | 7.8 | 12 |
| Renal bypass | 35.1 | 54 |
| Other abdominal procedure | 12.3 | 19 |
| EVAR conversion | 6.5 | 10 |
AAA, Abdominal aortic aneurysm; CAD, coronary artery disease; CHF, congestive heart failure; CKD, chronic kidney disease; COPD, chronic obstructive pulmonary disease; CTD, connective tissue disease; ESRD, end-stage renal disease; EVAR conversion, cases performed as an open conversion of a failed endovascular repair requiring concomitant explantation of the stent graft; HLD, hyperlipidemia; HTN, hypertension; IMA, inferior mesenteric artery; PVD, peripheral vascular disease; SD, standard deviation.